Bumper Offer - Urjas oil Just @ Rs. 1
Ziprax DT 200 Tablet (10), a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Ear Infection, Tonsillitis, Bronchitis. The alternative uses of Ziprax DT 200 Tablet (10) have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Ziprax DT 200 Tablet (10). Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Ziprax DT 200 Tablet (10) can also lead to other problems, which have been listed below. Usually, these side effects of Ziprax DT 200 Tablet (10) go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Ziprax DT 200 Tablet (10) has a Safe effect for pregnant women and Safe effect on lactating mothers. It is important to know if Ziprax DT 200 Tablet (10) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Ziprax DT 200 Tablet (10) related warnings section.
Some other conditions that can be affected by Ziprax DT 200 Tablet (10) are listed in the contraindications section below.
Drug interactions for Ziprax DT 200 Tablet (10) have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Ziprax DT 200 Tablet (10) is not safe while driving, and is not addiction.
Ziprax DT 200 Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ziprax DT 200 Tablet (10) is used -
Severe
Mild
Is the use of Ziprax DT 200 Tablet (10) safe for pregnant women?
Ziprax is safe for pregnant women.
Is the use of Ziprax DT 200 Tablet (10) safe during breastfeeding?
Ziprax is safe for breastfeeding women.
What is the effect of Ziprax DT 200 Tablet (10) on the Kidneys?
Ziprax rarely harms the kidneys.
What is the effect of Ziprax DT 200 Tablet (10) on the Liver?
There are no any side effects of Ziprax on the liver.
What is the effect of Ziprax DT 200 Tablet (10) on the Heart?
Ziprax is not harmful for the heart.
Ziprax DT 200 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ziprax DT 200 Tablet (10) unless your doctor advises you to do so -
Is this Ziprax DT 200 Tablet (10) habit forming or addictive?
Ziprax DT 200 Tablet (10) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Ziprax DT 200 Tablet (10) as you may feel sleepy.
Is it safe?
Yes, but consume Ziprax DT 200 Tablet (10) only on doctor's advice.
Is it able to treat mental disorders?
No, Ziprax DT 200 Tablet (10) is not used to treat mental disorders.
Interaction between Food and Ziprax DT 200 Tablet (10)
It is safe to take Ziprax DT 200 Tablet (10) with food.
Interaction between Alcohol and Ziprax DT 200 Tablet (10)
Due to lack of research, there is no information about the side effects of taking Ziprax DT 200 Tablet (10) with alcohol.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-309
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Suprax® (cefixime)